Cancer :: Interim analysis of anti-cancer vaccine, BiovaxID, to be conducted

Biovest International, Inc. (OTCBB: BVTI), a majority owned subsidiary of Accentia Biopharmaceuticals, Inc. (NASDAQ:ABPI) announces a milestone in its effort to gain accelerated conditional approval for BiovaxID?. The independent Data Monitoring Committee (DMC) has requested an interim analysis of all primary and secondary endpoints.

Rheumatoid Arthritis :: Breakthrough developments in rheumatoid arthritis reported

Peter K. Gregersen, MD, stares at x-rays of hands, searching out the telltale signs of inflamed joints and wrists from his research subjects with rheumatoid arthritis. With these clinical features at his side, he turns to the basic building blocks of life ? the human genome ? to figure out what makes these people susceptible to the disabling inflammatory condition.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack